Global Tubeless Insulin Pump Market research

Tubeless Insulin Pump Comprehensive Study by Type (Pod/Patch, Remote, Others), Application (Pharmacies, Hospitals, E-commerce, Others) Players and Region - Global Market Outlook to 2030

Tubeless Insulin Pump Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Tubeless Insulin Pump Market Scope
The tubeless insulin pump is a portable and effective controlling blood sugar level. This device eliminates the requirement of multiple injections daily. Rising prevalence of diabetes will accelerate the adoption rate of tubeless insulin pump systems as this avoids painless procedures and enhanced convenience in insulin delivery. Research and development activities are begin conducted for developing insulin delivery devices, this includes wearables and Bluetooth enabled equipment’s which is propelling the growth of the market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledMedtronic Plc. (Ireland), Tandem Diabetes Care (United States), Insulet Corporation (United States), Animas Corporation (United States), Insulet Corporation (United States), Johnson & Johnson (United States), Roche Holding AG (Switzerland), Cellnovo Group (United Kingdom), Debiotech (Switzerland), CeQur SA (Switzerland), Valeritas (United States) and Abbott Diabetes Care (United Kingdom)
CAGR%


Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Tubeless Insulin Pump market throughout the predicted period.

Medtronic Plc. (Ireland), Tandem Diabetes Care (United States), Insulet Corporation (United States), Animas Corporation (United States), Insulet Corporation (United States), Johnson & Johnson (United States), Roche Holding AG (Switzerland), Cellnovo Group (United Kingdom), Debiotech (Switzerland), CeQur SA (Switzerland), Valeritas (United States) and Abbott Diabetes Care (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Medtrum Technologies and Spring Health Solution.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Tubeless Insulin Pump market by Type , by Application (Pharmacies, Hospitals, E-commerce and Others) and Region with country level break-up.

On the basis of geography, the market of Tubeless Insulin Pump has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In July 2018, CeQur which develops and commercializes insulin delivery systems for type II diabetes patients announced acquisition with Calibra Medical one of the Johnson & Johnson Diabetes Care Companies. The acquisition was aimed at developing and manufacturing technologically advanced wearable insulin device for increasing product portfolio and bringing the technologically advanced product in the market.
In April 2019, Omnipod DASH announced about its launch of Omnipod DASH in the U.S. The device wirelessly connects with bolus material for identification of insulin level in the body and consistently delivers insulin at basal rate. It is enabled with Bluetooth meter integration, diabetes management app integrations, personal diabetes manager, new pods and other features for accurate administration of insulin in the body, thereby fortifying the company’s portfolio.
As per WHO, the global prevalence of diabetes among the adult population aged above 18 years was 8.5% in 2014 then 4.7% in 1980. Diabetes prevalence has been rising more rapidly in middle- and low-income countries. Moreover, insulin up-take is expected to rise significantly owing to the increasing number of diabetic patients across the globe.

Influencing Trend:
Development in Insulin Delivery Devices

Market Growth Drivers:
Rising Prevalence of Diabetes Is Accelerating the Adoption Rate of Tubeless Insulin Pump Systems and Increasing Government Initiatives and Growing Awareness About diabetes Influencing the Growth of Tubeless Insulin Pump

Challenges:
Stringent government regulations

Restraints:
Stringent Government Rules and Regulations for Approval of Tubeless Insulin Pump and High Cost Associated with Tubeless Insulin Pump

Opportunities:
Increase in Demand for Insulin Delivery Devices in Rural Areas and Growing Healthcare Infrastructure and Introduction of Newer Technologies Will Spur Tubeless Insulin Pump

Key Target Audience
Tubeless Insulin Pump Manufacturer, Raw Material Supplier, Tubeless Insulin Pump Wholeseller and Distributors, Associations and Government Bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Pod/Patch
  • Remote
  • Others
By Application
  • Pharmacies
  • Hospitals
  • E-commerce
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Diabetes Is Accelerating the Adoption Rate of Tubeless Insulin Pump Systems
      • 3.2.2. Increasing Government Initiatives and Growing Awareness About diabetes Influencing the Growth of Tubeless Insulin Pump
    • 3.3. Market Challenges
      • 3.3.1. Stringent government regulations
    • 3.4. Market Trends
      • 3.4.1. Development in Insulin Delivery Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Tubeless Insulin Pump, by Type, Application and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Tubeless Insulin Pump (Value)
      • 5.2.1. Global Tubeless Insulin Pump by: Type (Value)
        • 5.2.1.1. Pod/Patch
        • 5.2.1.2. Remote
        • 5.2.1.3. Others
      • 5.2.2. Global Tubeless Insulin Pump by: Application (Value)
        • 5.2.2.1. Pharmacies
        • 5.2.2.2. Hospitals
        • 5.2.2.3. E-commerce
        • 5.2.2.4. Others
      • 5.2.3. Global Tubeless Insulin Pump Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Tubeless Insulin Pump (Volume)
      • 5.3.1. Global Tubeless Insulin Pump by: Type (Volume)
        • 5.3.1.1. Pod/Patch
        • 5.3.1.2. Remote
        • 5.3.1.3. Others
      • 5.3.2. Global Tubeless Insulin Pump by: Application (Volume)
        • 5.3.2.1. Pharmacies
        • 5.3.2.2. Hospitals
        • 5.3.2.3. E-commerce
        • 5.3.2.4. Others
      • 5.3.3. Global Tubeless Insulin Pump Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Tubeless Insulin Pump (Price)
      • 5.4.1. Global Tubeless Insulin Pump by: Type (Price)
  • 6. Tubeless Insulin Pump: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic Plc. (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Tandem Diabetes Care (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Insulet Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Animas Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Insulet Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson & Johnson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Roche Holding AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cellnovo Group (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Debiotech (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. CeQur SA (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Valeritas (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Abbott Diabetes Care (United Kingdom)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Tubeless Insulin Pump Sale, by Type, Application and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Tubeless Insulin Pump (Value)
      • 7.2.1. Global Tubeless Insulin Pump by: Type (Value)
        • 7.2.1.1. Pod/Patch
        • 7.2.1.2. Remote
        • 7.2.1.3. Others
      • 7.2.2. Global Tubeless Insulin Pump by: Application (Value)
        • 7.2.2.1. Pharmacies
        • 7.2.2.2. Hospitals
        • 7.2.2.3. E-commerce
        • 7.2.2.4. Others
      • 7.2.3. Global Tubeless Insulin Pump Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Tubeless Insulin Pump (Volume)
      • 7.3.1. Global Tubeless Insulin Pump by: Type (Volume)
        • 7.3.1.1. Pod/Patch
        • 7.3.1.2. Remote
        • 7.3.1.3. Others
      • 7.3.2. Global Tubeless Insulin Pump by: Application (Volume)
        • 7.3.2.1. Pharmacies
        • 7.3.2.2. Hospitals
        • 7.3.2.3. E-commerce
        • 7.3.2.4. Others
      • 7.3.3. Global Tubeless Insulin Pump Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Tubeless Insulin Pump (Price)
      • 7.4.1. Global Tubeless Insulin Pump by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Tubeless Insulin Pump: by Type(USD Million)
  • Table 2. Tubeless Insulin Pump Pod/Patch , by Region USD Million (2018-2023)
  • Table 3. Tubeless Insulin Pump Remote , by Region USD Million (2018-2023)
  • Table 4. Tubeless Insulin Pump Others , by Region USD Million (2018-2023)
  • Table 5. Tubeless Insulin Pump: by Application(USD Million)
  • Table 6. Tubeless Insulin Pump Pharmacies , by Region USD Million (2018-2023)
  • Table 7. Tubeless Insulin Pump Hospitals , by Region USD Million (2018-2023)
  • Table 8. Tubeless Insulin Pump E-commerce , by Region USD Million (2018-2023)
  • Table 9. Tubeless Insulin Pump Others , by Region USD Million (2018-2023)
  • Table 10. South America Tubeless Insulin Pump, by Country USD Million (2018-2023)
  • Table 11. South America Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 12. South America Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 13. Brazil Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 14. Brazil Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 15. Argentina Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 16. Argentina Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 17. Rest of South America Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 19. Asia Pacific Tubeless Insulin Pump, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 22. China Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 23. China Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 24. Japan Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 25. Japan Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 26. India Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 27. India Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 28. South Korea Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 29. South Korea Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 30. Taiwan Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 31. Taiwan Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 32. Australia Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 33. Australia Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 36. Europe Tubeless Insulin Pump, by Country USD Million (2018-2023)
  • Table 37. Europe Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 38. Europe Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 39. Germany Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 40. Germany Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 41. France Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 42. France Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 43. Italy Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 44. Italy Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 45. United Kingdom Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 47. Netherlands Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 48. Netherlands Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 49. Rest of Europe Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 51. MEA Tubeless Insulin Pump, by Country USD Million (2018-2023)
  • Table 52. MEA Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 53. MEA Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 54. Middle East Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 55. Middle East Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 56. Africa Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 57. Africa Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 58. North America Tubeless Insulin Pump, by Country USD Million (2018-2023)
  • Table 59. North America Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 60. North America Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 61. United States Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 62. United States Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 63. Canada Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 64. Canada Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 65. Mexico Tubeless Insulin Pump, by Type USD Million (2018-2023)
  • Table 66. Mexico Tubeless Insulin Pump, by Application USD Million (2018-2023)
  • Table 67. Tubeless Insulin Pump Sales: by Type(K Unit)
  • Table 68. Tubeless Insulin Pump Sales Pod/Patch , by Region K Unit (2018-2023)
  • Table 69. Tubeless Insulin Pump Sales Remote , by Region K Unit (2018-2023)
  • Table 70. Tubeless Insulin Pump Sales Others , by Region K Unit (2018-2023)
  • Table 71. Tubeless Insulin Pump Sales: by Application(K Unit)
  • Table 72. Tubeless Insulin Pump Sales Pharmacies , by Region K Unit (2018-2023)
  • Table 73. Tubeless Insulin Pump Sales Hospitals , by Region K Unit (2018-2023)
  • Table 74. Tubeless Insulin Pump Sales E-commerce , by Region K Unit (2018-2023)
  • Table 75. Tubeless Insulin Pump Sales Others , by Region K Unit (2018-2023)
  • Table 76. South America Tubeless Insulin Pump Sales, by Country K Unit (2018-2023)
  • Table 77. South America Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 78. South America Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 79. Brazil Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 80. Brazil Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 81. Argentina Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 82. Argentina Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 83. Rest of South America Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 84. Rest of South America Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 85. Asia Pacific Tubeless Insulin Pump Sales, by Country K Unit (2018-2023)
  • Table 86. Asia Pacific Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 87. Asia Pacific Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 88. China Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 89. China Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 90. Japan Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 91. Japan Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 92. India Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 93. India Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 94. South Korea Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 95. South Korea Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 96. Taiwan Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 97. Taiwan Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 98. Australia Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 99. Australia Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 100. Rest of Asia-Pacific Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 101. Rest of Asia-Pacific Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 102. Europe Tubeless Insulin Pump Sales, by Country K Unit (2018-2023)
  • Table 103. Europe Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 104. Europe Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 105. Germany Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 106. Germany Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 107. France Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 108. France Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 109. Italy Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 110. Italy Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 111. United Kingdom Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 112. United Kingdom Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 113. Netherlands Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 114. Netherlands Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 115. Rest of Europe Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 116. Rest of Europe Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 117. MEA Tubeless Insulin Pump Sales, by Country K Unit (2018-2023)
  • Table 118. MEA Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 119. MEA Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 120. Middle East Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 121. Middle East Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 122. Africa Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 123. Africa Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 124. North America Tubeless Insulin Pump Sales, by Country K Unit (2018-2023)
  • Table 125. North America Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 126. North America Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 127. United States Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 128. United States Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 129. Canada Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 130. Canada Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 131. Mexico Tubeless Insulin Pump Sales, by Type K Unit (2018-2023)
  • Table 132. Mexico Tubeless Insulin Pump Sales, by Application K Unit (2018-2023)
  • Table 133. Tubeless Insulin Pump: by Type(USD/Units)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Tubeless Insulin Pump: by Type(USD Million)
  • Table 147. Tubeless Insulin Pump Pod/Patch , by Region USD Million (2025-2030)
  • Table 148. Tubeless Insulin Pump Remote , by Region USD Million (2025-2030)
  • Table 149. Tubeless Insulin Pump Others , by Region USD Million (2025-2030)
  • Table 150. Tubeless Insulin Pump: by Application(USD Million)
  • Table 151. Tubeless Insulin Pump Pharmacies , by Region USD Million (2025-2030)
  • Table 152. Tubeless Insulin Pump Hospitals , by Region USD Million (2025-2030)
  • Table 153. Tubeless Insulin Pump E-commerce , by Region USD Million (2025-2030)
  • Table 154. Tubeless Insulin Pump Others , by Region USD Million (2025-2030)
  • Table 155. South America Tubeless Insulin Pump, by Country USD Million (2025-2030)
  • Table 156. South America Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 157. South America Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 158. Brazil Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 159. Brazil Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 160. Argentina Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 161. Argentina Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 162. Rest of South America Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 163. Rest of South America Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 164. Asia Pacific Tubeless Insulin Pump, by Country USD Million (2025-2030)
  • Table 165. Asia Pacific Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 166. Asia Pacific Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 167. China Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 168. China Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 169. Japan Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 170. Japan Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 171. India Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 172. India Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 173. South Korea Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 174. South Korea Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 175. Taiwan Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 176. Taiwan Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 177. Australia Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 178. Australia Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 179. Rest of Asia-Pacific Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 180. Rest of Asia-Pacific Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 181. Europe Tubeless Insulin Pump, by Country USD Million (2025-2030)
  • Table 182. Europe Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 183. Europe Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 184. Germany Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 185. Germany Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 186. France Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 187. France Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 188. Italy Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 189. Italy Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 190. United Kingdom Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 191. United Kingdom Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 192. Netherlands Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 193. Netherlands Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 194. Rest of Europe Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 195. Rest of Europe Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 196. MEA Tubeless Insulin Pump, by Country USD Million (2025-2030)
  • Table 197. MEA Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 198. MEA Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 199. Middle East Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 200. Middle East Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 201. Africa Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 202. Africa Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 203. North America Tubeless Insulin Pump, by Country USD Million (2025-2030)
  • Table 204. North America Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 205. North America Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 206. United States Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 207. United States Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 208. Canada Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 209. Canada Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 210. Mexico Tubeless Insulin Pump, by Type USD Million (2025-2030)
  • Table 211. Mexico Tubeless Insulin Pump, by Application USD Million (2025-2030)
  • Table 212. Tubeless Insulin Pump Sales: by Type(K Unit)
  • Table 213. Tubeless Insulin Pump Sales Pod/Patch , by Region K Unit (2025-2030)
  • Table 214. Tubeless Insulin Pump Sales Remote , by Region K Unit (2025-2030)
  • Table 215. Tubeless Insulin Pump Sales Others , by Region K Unit (2025-2030)
  • Table 216. Tubeless Insulin Pump Sales: by Application(K Unit)
  • Table 217. Tubeless Insulin Pump Sales Pharmacies , by Region K Unit (2025-2030)
  • Table 218. Tubeless Insulin Pump Sales Hospitals , by Region K Unit (2025-2030)
  • Table 219. Tubeless Insulin Pump Sales E-commerce , by Region K Unit (2025-2030)
  • Table 220. Tubeless Insulin Pump Sales Others , by Region K Unit (2025-2030)
  • Table 221. South America Tubeless Insulin Pump Sales, by Country K Unit (2025-2030)
  • Table 222. South America Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 223. South America Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 224. Brazil Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 225. Brazil Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 226. Argentina Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 227. Argentina Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 228. Rest of South America Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 229. Rest of South America Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 230. Asia Pacific Tubeless Insulin Pump Sales, by Country K Unit (2025-2030)
  • Table 231. Asia Pacific Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 232. Asia Pacific Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 233. China Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 234. China Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 235. Japan Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 236. Japan Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 237. India Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 238. India Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 239. South Korea Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 240. South Korea Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 241. Taiwan Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 242. Taiwan Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 243. Australia Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 244. Australia Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 245. Rest of Asia-Pacific Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 246. Rest of Asia-Pacific Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 247. Europe Tubeless Insulin Pump Sales, by Country K Unit (2025-2030)
  • Table 248. Europe Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 249. Europe Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 250. Germany Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 251. Germany Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 252. France Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 253. France Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 254. Italy Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 255. Italy Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 256. United Kingdom Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 257. United Kingdom Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 258. Netherlands Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 259. Netherlands Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 260. Rest of Europe Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 261. Rest of Europe Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 262. MEA Tubeless Insulin Pump Sales, by Country K Unit (2025-2030)
  • Table 263. MEA Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 264. MEA Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 265. Middle East Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 266. Middle East Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 267. Africa Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 268. Africa Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 269. North America Tubeless Insulin Pump Sales, by Country K Unit (2025-2030)
  • Table 270. North America Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 271. North America Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 272. United States Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 273. United States Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 274. Canada Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 275. Canada Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 276. Mexico Tubeless Insulin Pump Sales, by Type K Unit (2025-2030)
  • Table 277. Mexico Tubeless Insulin Pump Sales, by Application K Unit (2025-2030)
  • Table 278. Tubeless Insulin Pump: by Type(USD/Units)
  • Table 279. Research Programs/Design for This Report
  • Table 280. Key Data Information from Secondary Sources
  • Table 281. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Tubeless Insulin Pump: by Type USD Million (2018-2023)
  • Figure 5. Global Tubeless Insulin Pump: by Application USD Million (2018-2023)
  • Figure 6. South America Tubeless Insulin Pump Share (%), by Country
  • Figure 7. Asia Pacific Tubeless Insulin Pump Share (%), by Country
  • Figure 8. Europe Tubeless Insulin Pump Share (%), by Country
  • Figure 9. MEA Tubeless Insulin Pump Share (%), by Country
  • Figure 10. North America Tubeless Insulin Pump Share (%), by Country
  • Figure 11. Global Tubeless Insulin Pump: by Type K Unit (2018-2023)
  • Figure 12. Global Tubeless Insulin Pump: by Application K Unit (2018-2023)
  • Figure 13. South America Tubeless Insulin Pump Share (%), by Country
  • Figure 14. Asia Pacific Tubeless Insulin Pump Share (%), by Country
  • Figure 15. Europe Tubeless Insulin Pump Share (%), by Country
  • Figure 16. MEA Tubeless Insulin Pump Share (%), by Country
  • Figure 17. North America Tubeless Insulin Pump Share (%), by Country
  • Figure 18. Global Tubeless Insulin Pump: by Type USD/Units (2018-2023)
  • Figure 19. Global Tubeless Insulin Pump share by Players 2023 (%)
  • Figure 20. Global Tubeless Insulin Pump share by Players (Top 3) 2023(%)
  • Figure 21. Global Tubeless Insulin Pump share by Players (Top 5) 2023(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Medtronic Plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 24. Medtronic Plc. (Ireland) Revenue: by Geography 2023
  • Figure 25. Tandem Diabetes Care (United States) Revenue, Net Income and Gross profit
  • Figure 26. Tandem Diabetes Care (United States) Revenue: by Geography 2023
  • Figure 27. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Insulet Corporation (United States) Revenue: by Geography 2023
  • Figure 29. Animas Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Animas Corporation (United States) Revenue: by Geography 2023
  • Figure 31. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Insulet Corporation (United States) Revenue: by Geography 2023
  • Figure 33. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 34. Johnson & Johnson (United States) Revenue: by Geography 2023
  • Figure 35. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Roche Holding AG (Switzerland) Revenue: by Geography 2023
  • Figure 37. Cellnovo Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Cellnovo Group (United Kingdom) Revenue: by Geography 2023
  • Figure 39. Debiotech (Switzerland) Revenue, Net Income and Gross profit
  • Figure 40. Debiotech (Switzerland) Revenue: by Geography 2023
  • Figure 41. CeQur SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. CeQur SA (Switzerland) Revenue: by Geography 2023
  • Figure 43. Valeritas (United States) Revenue, Net Income and Gross profit
  • Figure 44. Valeritas (United States) Revenue: by Geography 2023
  • Figure 45. Abbott Diabetes Care (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 46. Abbott Diabetes Care (United Kingdom) Revenue: by Geography 2023
  • Figure 47. Global Tubeless Insulin Pump: by Type USD Million (2025-2030)
  • Figure 48. Global Tubeless Insulin Pump: by Application USD Million (2025-2030)
  • Figure 49. South America Tubeless Insulin Pump Share (%), by Country
  • Figure 50. Asia Pacific Tubeless Insulin Pump Share (%), by Country
  • Figure 51. Europe Tubeless Insulin Pump Share (%), by Country
  • Figure 52. MEA Tubeless Insulin Pump Share (%), by Country
  • Figure 53. North America Tubeless Insulin Pump Share (%), by Country
  • Figure 54. Global Tubeless Insulin Pump: by Type K Unit (2025-2030)
  • Figure 55. Global Tubeless Insulin Pump: by Application K Unit (2025-2030)
  • Figure 56. South America Tubeless Insulin Pump Share (%), by Country
  • Figure 57. Asia Pacific Tubeless Insulin Pump Share (%), by Country
  • Figure 58. Europe Tubeless Insulin Pump Share (%), by Country
  • Figure 59. MEA Tubeless Insulin Pump Share (%), by Country
  • Figure 60. North America Tubeless Insulin Pump Share (%), by Country
  • Figure 61. Global Tubeless Insulin Pump: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Medtronic Plc. (Ireland)
  • Tandem Diabetes Care (United States)
  • Insulet Corporation (United States)
  • Animas Corporation (United States)
  • Insulet Corporation (United States)
  • Johnson & Johnson (United States)
  • Roche Holding AG (Switzerland)
  • Cellnovo Group (United Kingdom)
  • Debiotech (Switzerland)
  • CeQur SA (Switzerland)
  • Valeritas (United States)
  • Abbott Diabetes Care (United Kingdom)
Additional players considered in the study are as follows:
Medtrum Technologies , Spring Health Solution
Select User Access Type

Key Highlights of Report


Apr 2024 233 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Tubeless Insulin Pump Market research Quantitative research analysis
Global Tubeless Insulin Pump Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Tubeless Insulin Pump Market are by type [Pod/Patch, Remote and Others], by end use application [Pharmacies, Hospitals, E-commerce and Others].
The Tubeless Insulin Pump Market is gaining popularity and expected to see strong valuation by 2030.
  • Rising Prevalence of Diabetes Is Accelerating the Adoption Rate of Tubeless Insulin Pump Systems
  • Increasing Government Initiatives and Growing Awareness About diabetes Influencing the Growth of Tubeless Insulin Pump

Know More About Global Tubeless Insulin Pump Market research Report?

Have a Query? Click Here

Other Related Reports

Lemon Terpenes Comprehensive Study by Type (Purity 95%, Purity 98%, Other), Application (Cosmetics, Medical, Edible Flavor, Other), Distribution Channel (Supplier, Distributer, Retailer, Others) Play...
$ 3500
Health Functional Food Comprehensive Study by Type (Tablets, Capsules, Powders, Others), Application (Sports Nutrition, Weight Management Food, Dietary Supplements, Other), Ingredients (Dietary Fiber...
$ 3450
Thawing System Comprehensive Study by Type (Manual Devices, Automated Devices), Application (Blood Banks & Transfusion Centers, Hospitals & Diagnostic Laboratories, Cord Blood and Stem Cell Banks, Re...
$ 3750
Laser Eye Shield Comprehensive Study by Type (Autoclavable, Single-Use), Application (Hospital, Clinic, Personal Care, Other), Distribution Channel (Online, Offline) Players and Region - Global Marke...
$ 3500
Roman Chamomile Oil Comprehensive Study by Type (Natural, Synthetic), Application (Cosmetics, Medical, Others), Quality (High-Quality, Middle-Quality, Low-Quality), End Use (Aromatherapy, Personal Ca...
$ 3450
Dental Consumables Comprehensive Study by Type (Dental Restoration, Prosthetics, Endodontics, Orthodontics, Whitening Products, Finishing Products, Others), Material Type (Metals, Polymers, Ceramics,...
$ 3500